In one study, people who took 2.4 mg of semaglutide every week for 68 weeks lost an average of 14.9% of their total body weight
Originally studied for metabolic and glycemic control, semaglutide has since demonstrated significant efficacy in promoting sustained weight reduction by targeting the physiological drivers of appetite, caloric intake, and metabolic efficiency
They also slow gastric emptying, helping to prevent sudden blood sugar spikes
Without robust clinical trial data examining this specific combination, it is not possible to fully characterise the risk profile
#peptides #BPC157 #PerformanceMedicine #HumanPerformance #Longevity #Biohacking #ConciergeMedicine Im not pro or against RUO peptides
Instant 'Red Carpet' luminosity featuring minimal social downtime, allowing you to confidently return to professional work or major events immediately